» Articles » PMID: 18355811

Systemic Inflammation Exacerbates Behavioral and Histopathological Consequences of Isolated Traumatic Brain Injury in Rats

Overview
Journal Exp Neurol
Specialty Neurology
Date 2008 Mar 22
PMID 18355811
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The proinflammatory cytokine interleukin-1beta (IL-1beta) is induced rapidly after traumatic brain injury (TBI) and contributes to the inflammatory events that lead to neuronal loss. Although an important source of IL-1beta is from the injured brain itself, in patients with multiple organ trauma (polytrauma) IL-1beta is also released into the bloodstream which may potentially influence brain vulnerability. The purpose of this study was to determine the effects of systemic inflammation induced by peripheral administration of IL-1beta on histopathological and behavioral outcome after moderate fluid percussion (FP) brain injury in rats. At 30 min or 24 h after TBI, saline, 20 mug/kg or 40 mug/kg of IL-1beta was injected (n=4-9/group) intraperitoneally (IP). Sham operated animals (n=9) received either saline or IL-1beta (20 or 40 mug/kg) injections. The somatosensory tactile placing test was administered at 1, 2 and 3 days posttrauma. IL-1beta-treated animals showed significant placing deficits compared to vehicle-treated TBI animals. Three days after injection, contusion areas and volumes were significantly increased (p<0.05) with both IL-1beta doses and at both treatment times compared to vehicle-treated animals. IL-1beta-treated rats showed more contusion injury and hippocampal neuronal damage as well as enhanced perivascular neutrophil accumulation. Cortical IL-1r1 mRNA increased as early as 1 h following TBI, peaking at 24 h and remained elevated 3 days posttrauma. These data show that the posttraumatic administration of IL-1beta significantly aggravates behavioral outcome and increases overall contusion volume after TBI. Increased systemic inflammatory processes, including extravasation of activated leukocytes and proinflammatory cytokines could participate in this detrimental outcome. Because peripherally circulating cytokines and other neurotoxic factors may be increased following multi-organ trauma, these findings may be important in targeting therapeutic interventions in this patient population.

Citing Articles

Peripheral immune reactions following human traumatic spinal cord injury: the interplay of immune activation and suppression.

Coenen H, Somers V, Fraussen J Front Immunol. 2024; 15():1495801.

PMID: 39664385 PMC: 11631733. DOI: 10.3389/fimmu.2024.1495801.


Prospects for Nerve Regeneration and Gene Therapy in the Treatment of Traumatic Brain Injury.

Wang D, Wang S, Zhu Q, Shen Z, Yang G, Chen Y J Mol Neurosci. 2023; 73(7-8):578-586.

PMID: 37458921 DOI: 10.1007/s12031-023-02144-9.


Partial Depletion of Microglia Attenuates Long-Term Potentiation Deficits following Repeated Blast Traumatic Brain Injury in Organotypic Hippocampal Slice Cultures.

Varghese N, Morrison 3rd B J Neurotrauma. 2022; 40(5-6):547-560.

PMID: 36508265 PMC: 10081725. DOI: 10.1089/neu.2022.0284.


NS1619 Alleviate Brain-Derived Extracellular Vesicle-Induced Brain Injury by Regulating BKca Channel and Nrf2/HO-1/NF-ĸB Pathway.

Gao Y, Zhang H, Li X, Li L, Li F, Li T Oxid Med Cell Longev. 2022; 2022:2257427.

PMID: 36466093 PMC: 9711983. DOI: 10.1155/2022/2257427.


Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain Injury.

Hsueh S, Scerba M, Tweedie D, Lecca D, Kim D, Baig A Biomedicines. 2022; 10(10).

PMID: 36289711 PMC: 9598880. DOI: 10.3390/biomedicines10102449.


References
1.
Stamatovic S, Dimitrijevic O, Keep R, Andjelkovic A . Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl. 2006; 96:444-50. DOI: 10.1007/3-211-30714-1_91. View

2.
Dietrich W, Alonso O, Halley M . Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma. 1994; 11(3):289-301. DOI: 10.1089/neu.1994.11.289. View

3.
Lucas S, Rothwell N, Gibson R . The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006; 147 Suppl 1:S232-40. PMC: 1760754. DOI: 10.1038/sj.bjp.0706400. View

4.
Schonbeck U, Mach F, Libby P . Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol. 1998; 161(7):3340-6. View

5.
Fassbender K, Schneider S, Bertsch T, Schlueter D, Fatar M, Ragoschke A . Temporal profile of release of interleukin-1beta in neurotrauma. Neurosci Lett. 2000; 284(3):135-8. DOI: 10.1016/s0304-3940(00)00977-0. View